BriaCell Therapeutics Corp.
SEC Filing List
BCTX CIK: 0001610820
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 06/26/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 06/09/2026 | |
| 8-K | Current report filing | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 06/03/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 06/02/2026 | |
| 8-K | Current report filing | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 03/31/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 03/10/2026 | |
| 8-K | Current report filing | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 03/09/2026 | |
| 25-NSE | Notification filed by national security ... | 02/26/2026 | |||
| 8-K | Current report filing | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 02/20/2026 | |
| DEF 14A | Definitive proxy statements | Briacell Therapeutics Corp. | M2 COMPLIANCE LLC /fa | 02/12/2026 | |
| No record found. | |||||
| Load More | |||||
